Diamyd Medical AB (publ) (DMYD-B.ST)
SEK 16.12
(2.54%)
SEK 16.12
(2.54%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -129.18 Million | -110.96 Million | -93.21 Million | -109.46 Million | 16.88 Million | -39.18 Million |
| Net Income | -151.85 Million | -120.8 Million | -118.17 Million | -85.88 Million | 9.73 Million | -36.56 Million |
| Depreciation & Amortization | 5.58 Million | 4.86 Million | 4.38 Million | 782 Thousand | 149 Thousand | 140 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -13.5 Million | -1.44 Million | 17.52 Million | -24.66 Million | 6.98 Million | -1.8 Million |
| Other non-cash items | 30.59 Million | 6.42 Million | 3.05 Million | 291 Thousand | 5000.00 | -955 Thousand |
| Investing Cash Flow | -27.99 Million | 28.4 Million | -76.72 Million | 132.53 Million | 4.82 Million | 5.35 Million |
| Investments in PPE | -8.02 Million | -11.44 Million | -34.65 Million | -4.22 Million | -1.97 Million | - |
| Acquisitions | - | -39.84 Million | 6.65 Million | 144.41 Million | -6.8 Million | - |
| Investment purchases | -40.35 Million | -64 Thousand | -129.89 Million | -20.47 Million | -33.2 Million | -94.72 Million |
| Sales/Maturities of investments | 20.38 Million | 39.9 Million | 96.63 Million | 157.23 Million | 40 Million | 100.07 Million |
| Other Investing Activities | -19.96 Million | 39.84 Million | -15.46 Million | -144.41 Million | 6.8 Million | 1000.00 |
| Financing Cash Flow | 142.28 Million | 86.54 Million | 142.15 Million | 56.72 Million | -1000.00 | 56.38 Million |
| Debt repayment | -14.8 Million | -15.86 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 127.47 Million | 75.27 Million | 150 Million | 60 Million | - | 58.4 Million |
| Other Financing Activities | 142.28 Million | 27.13 Million | -7.84 Million | -3.27 Million | - | -2.02 Million |
| Accounts receivables | -13.5 Million | 66 Thousand | 10.09 Million | -19.56 Million | 1.13 Million | -2.08 Million |
| Accounts payables | 21.41 Million | -1.51 Million | 7.42 Million | -5.09 Million | 5.85 Million | 284 Thousand |
| Inventory | - | 1.51 Million | -7.42 Million | 5.09 Million | -5.85 Million | -284 Thousand |
| Other working capital | - | -1.51 Million | 7.42 Million | -5.09 Million | 5.85 Million | 284 Thousand |
| Cash at beginning of period | 127.53 Million | 119.76 Million | 139.37 Million | 58.36 Million | 36.7 Million | 14.07 Million |
| Cash at end of period | 112.75 Million | 127.53 Million | 119.76 Million | 139.37 Million | 58.36 Million | 36.7 Million |
| Capital Expenditure | -8.02 Million | -11.44 Million | -34.65 Million | -4.22 Million | -1.97 Million | - |
| Effect of forex changes on cash | 116 Thousand | 3.79 Million | 8.17 Million | 1.22 Million | -35 Thousand | 81 Thousand |
| Net cash flow / Change in cash | -14.77 Million | 7.77 Million | -19.61 Million | 81 Million | 21.66 Million | 22.62 Million |
| Free Cash Flow | -137.2 Million | -122.4 Million | -127.87 Million | -113.69 Million | 14.9 Million | -39.18 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -49.74 Million | -40.07 Million | -29.25 Million | -32.02 Million | -120.8 Million | -38.73 Million |
| Depreciation & Amortization | 6.88 Million | 1.45 Million | 1.35 Million | 1.3 Million | 4.86 Million | 1.31 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 14.85 Million | 1.73 Million | -9.44 Million | 765 Thousand | -1.44 Million | 726 Thousand |
| Other non-cash items | -1.16 Million | 1.29 Million | 1.91 Million | 2.14 Million | 6.42 Million | 2.16 Million |
| Investing Cash Flow | 18.79 Million | -39.97 Million | -3.47 Million | -3.34 Million | 28.4 Million | -2.39 Million |
| Investments in PPE | -588 Thousand | -622 Thousand | -3.47 Million | -3.34 Million | -11.44 Million | -2.39 Million |
| Acquisitions | - | - | - | - | -39.84 Million | - |
| Investment purchases | -1 Million | -39.35 Million | - | - | -64 Thousand | - |
| Sales/Maturities of investments | 20.38 Million | - | - | - | 39.9 Million | - |
| Other Investing Activities | 19.38 Million | -39.35 Million | - | - | 39.84 Million | - |
| Financing Cash Flow | -838 Thousand | 61.43 Million | -209 Thousand | 81.89 Million | 86.54 Million | 86.54 Million |
| Debt repayment | -901 Thousand | -7.42 Million | - | -8.28 Million | -15.86 Million | -15.86 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 63 Thousand | 54.01 Million | -209 Thousand | 77.9 Million | 75.27 Million | 75.27 Million |
| Other Financing Activities | -838 Thousand | 61.43 Million | -209 Thousand | 12.27 Million | 27.13 Million | 27.13 Million |
| Accounts receivables | -5.72 Million | 1.59 Million | -1.63 Million | -7.73 Million | 66 Thousand | 619 Thousand |
| Accounts payables | 20.58 Million | 140 Thousand | -7.81 Million | 8.5 Million | -1.51 Million | 107 Thousand |
| Inventory | - | - | - | - | 1.51 Million | 1.51 Million |
| Other working capital | 14.85 Million | - | - | - | -1.51 Million | -1.51 Million |
| Cash at beginning of period | 123.03 Million | 137.14 Million | 176.72 Million | 127.53 Million | 119.76 Million | 77.31 Million |
| Cash at end of period | 112.75 Million | 123.03 Million | 137.14 Million | 176.72 Million | 127.53 Million | 127.53 Million |
| Capital Expenditure | -588 Thousand | -622 Thousand | -3.47 Million | -3.34 Million | -11.44 Million | -2.39 Million |
| Effect of forex changes on cash | 933 Thousand | 1.19 Million | -458 Thousand | -1.55 Million | 3.79 Million | 597 Thousand |
| Net cash flow / Change in cash | -10.27 Million | -14.11 Million | -39.57 Million | 49.18 Million | 7.77 Million | 50.22 Million |
| Free Cash Flow | -29.75 Million | -37.39 Million | -38.9 Million | -31.15 Million | -122.4 Million | -36.91 Million |
CNQQF
SPELS
RATHF
CETI
601200
1918